Meeting Information - The company will hold its second extraordinary general meeting of shareholders in 2025 on September 8, 2025, at 15:30 [1] - The meeting complies with relevant laws and regulations, including the Company Law and Securities Law of the People's Republic of China [1] Voting Procedures - Shareholders can vote through both on-site and online platforms, with specific time slots for online voting on September 8, 2025 [2] - Shareholders must choose either on-site or online voting, and duplicate votes will be counted as the first valid vote [2] Agenda Items - The meeting will discuss several proposals, including changes to the registered capital and amendments to the company's articles of association [3] - Other proposals include revisions to various governance rules and the issuance of H shares for listing on the Hong Kong Stock Exchange [4][5] Registration Requirements - Personal shareholders must present their ID and provide copies of relevant documents to register for the meeting [6][7] - Corporate shareholders must provide documentation including a business license and a power of attorney for their representatives [6][7] Contact Information - The company has provided contact details for inquiries regarding the meeting, including an email address and phone number [8]

Core Viewpoint - The company plans to issue H shares and list them on the Hong Kong Stock Exchange to enhance its capital strength, competitiveness, and international brand image, aligning with its global strategy [2][3][4]. Group 1: H Share Issuance - The Supervisory Board approved the proposal for the issuance of H shares, which will be listed on the Hong Kong Stock Exchange [1][2]. - The issuance aims to meet the needs of the company's international business development and does not harm the interests of shareholders, especially minority investors [2][3]. - The proposed H shares will have a nominal value of RMB 1 and will be offered in foreign currency [2][4]. Group 2: Issuance Plan and Approval - The issuance plan includes both public offerings in Hong Kong and international placements to qualified institutional investors [3][4]. - The final issuance scale will be determined based on market conditions and regulatory approvals, with a maximum of 15% over-allotment option [4][5]. - The pricing of the shares will be market-driven, considering existing shareholders' interests and investor acceptance [5][6]. Group 3: Fund Utilization - The funds raised from the issuance will be used for overseas factory construction, global capacity expansion, and working capital supplementation [9][10]. - The company will have the authority to adjust the specific use of the raised funds based on regulatory feedback and operational needs [10]. Group 4: Corporate Structure Changes - Following the issuance, the company will transition to a foreign-funded joint-stock company, which complies with relevant laws and regulations [7][8]. - The validity period for the resolutions related to the issuance is set for 24 months from the date of approval by the shareholders' meeting [8][12]. Group 5: Previous Fund Usage and Auditing - The Supervisory Board reviewed and approved the report on the usage of previously raised funds, confirming compliance with regulations and no misappropriation of funds [9][10]. - The company has appointed an auditing firm for the H share issuance process [11].